AI-generated summary
The authors retrospectively reviewed patients with head and neck cancer treated with radiotherapy with or without cisplatin chemotherapy between 2005 and 2009, comparing those who received photobiomodulation for severe mucositis with those who did not. They report no statistical evidence that photobiomodulation was related to overall survival, progression-free survival, or local recurrence after adjusting for prognostic factors. The study was retrospective, so differences in treatment assignment may affect the comparison.
- Who or what was studied
- Patients diagnosed with head and neck cancer between 2005 and 2009 who received intensity-modulated radiotherapy with or without cisplatin-based chemotherapy
- Limits stated in the abstract
- The study is retrospective, and patients were not randomized, so the comparison between treated and untreated groups may be affected by selection and confounding.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Low-level laser therapy, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.